Line K. Skaanning

Prof. Line K. Skaanning

academic employee
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
LSLine K. Skaanning
Line K. Skaanning
Angelo SantoroAngelo Santoro
Angelo Santoro
TPThomas Pedersen
Thomas Pedersen
JMJacob Hertz Martinsen
Jacob Hertz Martinsen
Anna Maria D’UrsiAnna Maria D’Ursi
Anna Maria D’Ursi
BKBirthe Kragelund
Birthe Kragelund
The intrinsically disordered protein α-synuclein (aSN) is, in its fibrillated state, the main component of Lewy bodies—hallmarks of Parkinson’s disease. Additional Lewy body components include glycosaminoglycans, including heparan sulfate proteoglycans. In humans, heparan sulfate has, in an age-dependent manner, shown increased levels of sulfation. Heparin, a highly sulfated glycosaminoglycan, is a relevant mimic for mature heparan sulfate and has been shown to influence aSN fibrillation. Here, we decompose the underlying properties of the interaction between heparin and aSN and the effect of heparin on fibrillation. Via the isolation of the first 61 residues of aSN, which lacked intrinsic fibrillation propensity, fibrillation could be induced by heparin, and access to the initial steps in fibrillation was possible. Here, structural changes with shifts from disorder via type I β-turns to β-sheets were revealed, correlating with an increase in the aSN1–61/heparin molar ratio. Fluorescence microscopy revealed that heparin and aSN1–61 co-exist in the final fibrils. We conclude that heparin can induce the fibrillation of aSN1–61, through binding to the N-terminal with an affinity that is higher in the truncated form of aSN. It does so by specifically modulating the structure of aSN via the formation of type I β-turn structures likely critical for triggering aSN fibrillation.

26 July 2022 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
ASAltair B. Dos Santos
Altair B. Dos Santos
LSLine K. Skaanning
Line K. Skaanning
STSiganya Thaneshwaran
Siganya Thaneshwaran
EMEyd Mikkelsen
Eyd Mikkelsen
CRCesar R. Romero-Leguizamón
Cesar R. Romero-Leguizamón
KKKristi Anne Kohlmeier
Kristi Anne Kohlmeier

17 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMustapha Carab Ahmed
Mustapha Carab Ahmed
LSLine K. Skaanning
Line K. Skaanning
AJAlexander Jussupow
Alexander Jussupow
ENEstella Anne Newcombe
Estella Anne Newcombe
BKBirthe Kragelund
Birthe Kragelund
KLKresten Lindorff-Larsen
Kresten Lindorff-Larsen
The inherent flexibility of intrinsically disordered proteins (IDPs) makes it difficult to interpret experimental data using structural models. On the other hand, molecular dynamics simulations of IDPs often suffer from force-field inaccuracies, and long simulations times or enhanced sampling methods are needed to obtain converged ensembles. Here, we apply metainference and Bayesian/Maximum Entropy reweighting approaches to integrate prior knowledge of the system with experimental data, while also dealing with various sources of errors and the inherent conformational heterogeneity of IDPs. We have measured new SAXS data on the protein α -synuclein, and integrate this with simulations performed using different force fields. We find that if the force field gives rise to ensembles that are much more compact than what is implied by the SAXS data it is difficult to recover a reasonable ensemble. On the other hand, we show that when the simulated ensemble is reasonable, we can obtain an ensemble that is consistent with the SAXS data, but also with NMR diffusion and paramagnetic relaxation enhancement data.